Company intelligence
Faeth Therapeutics
Unlocking the power of metabolism to treat cancer.
Biotechnology Research
Austin (but entirely remote!), US
44 employees
1 public signals
About Faeth Therapeutics
Faeth Therapeutics is a clinical-stage biotechnology company pioneering multi-node inhibition of the PAM (PI3K/AKT/mTOR) pathway, one of the most frequently altered oncogenic pathways in cancer. Our lead program, PIKTOR, is an investigational all-oral combination designed to achieve deeper pathway suppression with greater tolerability by targeting multiple nodes simultaneously. We are advancing a pipeline of therapies with the goal of improving outcomes for patients with some of the most challenging cancers.
Verified activity
Signals from Faeth Therapeutics
1 published signal